Distal pancreatectomy with celiac axis resection for pancreatic body cancer

Ao-ran ZHANG,Yin-mo YANG
DOI: https://doi.org/10.19538/j.cjps.issn1005-2208.2017.03.13
2017-01-01
Abstract:Although lack of high quality evidences, most of retrospective research shows that distal pancreatectomy with celiac axis resection seems to be a safe and valuable option for selected patients of pancreatic body cancer involving celiac axis or/and its branches, and neoadjuvant therapy may bring additional survival benefits to these patients. Due to its relatively high perioperative risks, especially the ischemic morbidity, this procedure should only be performed after strict selection of cases aiming at R0 resection.
What problem does this paper attempt to address?